STEM-PD / Lund University, Novo Nordisk 
Welcome,         Profile    Billing    Logout  
  Diseases    Trials    Trials    News 
2 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
STEM-PD / Lund University, Novo Nordisk
2021-001366-38: A trial to determine the safety and tolerability of transplanted stem cell-derived dopamine neurons to the brains of individuals with Parkinson’s Disease.

Not yet recruiting
1/2
8
Europe
STEM-PD Product, STEM-PD Product, Suspension for injection
Region Skåne – Skåne University Hospital, Lund University
Parkinson’s disease, Parkinson’s disease, Diseases [C] - Nervous System Diseases [C10]
 
 
STEM-PD, NCT05635409: A Trial to Determine the Safety and Tolerability of Transplanted Stem Cell Derived Dopamine Neurons to the Brains of Individuals With Parkinson's Disease

Recruiting
1
8
Europe
STEM-PD
Region Skane, Lund University, Cambridge University Hospitals NHS Foundation Trust, University of Cambridge
Parkinson Disease
01/27
06/27

Download Options